. KI67 expression marks actively proliferating cells in both tissue and culture derivative. b) Immunohistological staining of 278_T_CELL is characterized by generating sphere-like structures that stain for Ezrin (green), F-actin (red) and nuclei (blue). Scale bars for all images: 50 µm. Three sample groups with characteristic CNV patterns are shown: hypoploid (outer circle, n=43), chromosomally stable MSI (middle circle, n=8) and hyperploid (inner circle, n=40) . Recurrently amplified (IGF2, red) or deleted genes (SMAD4, MACROD2, FHIT, PTEN and RBFOX1, blue) are noted. b) Distribution of additional chromosomal losses and gains in models compared to the original tumour for each CNV group (hypoploid: n=28, hyperploid: n=21, MSI: n=6) . Note the significant loss of genetic material in models derived from hypoploid tumours (p-value = 0.005, t-test) and the gain in models derived from hyperploid samples (P = 0.04, t-test).
All non-synonymous SNVs + Indels damaging and expressed non-synonymous SNVs + Indels FBXW7  DMD  TCF7L2  SMAD4  ATM  FAM123B  TGFBR2  ARID1A  BRAF  NRAS  GRIK3  WBSCR17  MTOR  POLE  SMAD2  ACVR1B  RIMS1  ERBB3  MYO1B  SLC9A9  MLL2  RNF43  TCERG1  BRCA2  CTNNB1  EDNRB  EGFR  FZD3  MAP7  PTPN12  CASP8  JARID2  PIK3R1  SOX9  ATP6V0D2  CDC27  CR1  CRNKL1  ERBB2  PTEN  ARHGAP28  CELSR1  IGF1R  ZHX3  DICER1  IDH2  KIF26B  NAP1L3  NR4A2  SMARCA4  CEP63  DUSP16  EVPL  GNAS  ING1  LSM14A  PCBP1  TOP2B  B2M  MACROD2  MAP2K1  PTPN11  UBXN11  DDX1  INPPL1  MYO18A  PANK3  POM121  PPP2R1A  TSC22D2  ZBTB7A  IDH1  KCNJ12  SMARCB1  AKT1  AURKA  CLEC14A  PASD1  RPL10L On the left all detected non-synonymous SNVs and on the right damaging and expressed non-synonymous SNVs were considered for the OT cohorts (tumour purity ≥40%; see methods). Cancer-relevant genes are shown, mentioned in the TCGA or PAN study, or recurrently mutated genes in OT (see methods). a) Scatter plots showing mutation frequencies in OT and in TCGA. Genes with a frequency >15% in either data set are labeled. b) Dotplot of mutation frequencies in TCGA (orange), OT patient (green), OT_PDX (blue) and OT_PDO (pink) are shown. Significant differences in frequencies between TCGA and OT are marked by arrows and grey a background (binomial test; FDR < 0.05). OT-PDO Early passage Late passage NMFa_PDO NMFb_PDO C E L C L C E L C E L % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % 3 2 1 1 1 L E C mutation was found mutation was not found low coverage (<10 reads) NRAS  SMAD4  TP53  ARHGAP28  ARID1A  ATM  CELSR1  DUSP16  INPPL1  ERBB2  PIK3R1  POLE  POM121  PTEN  TGFBR2  FAM123B  FZD3  SOX9  TCF7L2  SMARCA4 162_T  100_MET  159_T  148_T  102_MET  135_T  168_T  175_T  142_T  212_T  123_T  134_T  109_T  170_T2  250_T  233_MET  155_T  154_MET  195_T  103_MET  315_MET  167_T  170_T1  101_MET  235_MET  152_T  118_T1  227_T  114_T  206_T  132_T  288_MET  160_T  292_MET  118_T2  286_T  105_T  133_T  215_T  163_T  319_T  330_T  300_T  329_T  364_MET  116_T  201_T2  108_T  153_T  202_T  118_MET  277_MET  190_T  191_T  165_T  164_T  172_T  112_T  269_T  234_T  323_T  111_T  261_T  289_T  320_T  113_T  183_T  193_T  210_T  273_T  238_T  181_T  185_T  161_T  189_T  351_MET  352_MET  176_T  194_T  278_T  327_T  372_T1  106_T  157_T Height   99   91  95  98  98  99  93  96  98  100  89  98  99  98  97  86  91  95  95  88  89  81  83  60  100  82  92  84  85  57  83  91  85  97  85  70  93  79  83  81  89  87  81  87  64   88  66  89  70  98  70  64  80  95  91  77  64  94  91  85  98  96 ≥40%) . a) Hierarchical clustering of the patient tumours according to DNA methylation data. The primary tumour cohort was used to identify the top 5% most variable probes by median absolute deviation (MAD) (n= 22,358). These probes were used to cluster both metastatic and primary samples. Methylation per probe is expressed as beta value and given as a continuous colour code with no/low methylation in blue to high methylation in red. Four different probe sets were identified: probe set 1 (n= 7,025) localized mostly in gene promoters and in CpG islands (CGI's) and defined the CpG Island Methylator Phenotype (CIMP) identifying the CIMP-Low and CIMP-High tumour groups, displaying also pervasive CIMP; probe set 2 (n= 3,759) and probe set 3 (n= 7,858) corresponded to low CpG density loci either in intergenic regions and gene bodies or within 3'UTRs, respectively; probe set 4 (n= 3,716) was less defined, albeit slightly enriched for promoters in CGIs and CGI shores. The two additional patient groups 2 and 4 were defined by DNA methylation patterns involving probe sets 1, 2 and 3. The most methylated tumour group was CIMP-H, followed by patient group 2, then by group 4 and CIMP-L exhibiting the least methylation. Four major groups of tumours could be identified: CIMP-L (n=15), CIMP-H (n=16), patient group 2 (n=37) and patient group 4 (n=14). The three main molecular groups (ECM/EMT, ASCL2/MYC and Entero/Goblets) are coloured above the heatmap. MSI samples are marked at the bottom and cluster in the CIMP-H and patient 4 group. b) Sankey plot showing the correspondence from the four methylation groups into the three OT main groups (ECM/EMT, ASCL2/MYC and Entero/Goblets). The graph shows the cophenetic scores for the tested clusters 2-8. Within the graph the consensus matrix for the cluster size two is shown for PDO (left) and PDX models (right). b) Functional annotation of NMF groups in PDO and PDX models using the GePS Genomatix software. 116_T_XEN   208_MET1_XEN  161_T_XEN  209_T2_XEN  109_T_XEN  216_T_XEN  234_T_XEN  159_T_XEN  154_MET_XEN  230_T_XEN  278_T_XEN  372_T1_XEN  209_MET2_XEN  327_T_XEN  171_MET1_XEN  171_MET2_XEN  352_MET_XEN  323_T_XEN  277_MET_XEN  227_T_XEN  118_T1_XEN  299_T1_XEN  135_T_XEN  150_MET1_XEN1  100_MET_XEN  106_T_XEN  353_T_XEN  289_T_XEN  157_T_XEN  302_MET_XEN  151_MET_XEN  261_T_XEN  280_T_XEN  283_T_XEN  184_T_XEN  238_T_XEN  150_MET1_XEN4  150_MET1_XEN5  102_MET_XEN  128_T_XEN  181_T_XEN  111_T_XEN  155_T_XEN  212_T_XEN  114_T_XEN  320_T_XEN  183_T_XEN  150_MET1_XEN2  108_T_XEN  150_MET2_XEN  190_T_XEN PDO   327_T_CELL  108_T_XEN_CELL  190_T_CELL  116_T_XEN_CELL  330_T_CELL  299_T1_CELL  326_T_CELL  276_T_CELL  159_T_CELL  227_T_CELL  250_T_CELL  162_T_CELL  163_T_CELL  152_T_CELL  281_T_CELL  114_T_XEN_CELL  151_MET_CELL1  155_T_XEN_CELL  161_T_XEN_CELL  170_T2_CELL  195_T_CELL2  209_MET2_CELL  216_T_CELL  234_T_CELL  238_T_CELL  239_T_CELL  261_T_CELL  288_MET_CELL  292_MET_CELL  300_T_CELL  302_MET_CELL  315_MET_CELL  352_MET_CELL Irinotecan   327_T  108_T  190_T  116_T  299_T1  159_T  227_T  114_T  151_METa  155_T  161_T  209_MET2  216_T  234_T  238_T  261_T  278_T  302_MET 114_T_XEN_CELL  161_T_XEN_CELL  302_MET_CELL  239_T_CELL  151_MET_CELL1  315_MET_CELL  238_T_CELL  163_T_CELL  288_MET_CELL  170_T2_CELL  209_MET2_CELL  234_T_CELL  300_T_CELL  281_T_CELL  278_T_CELL  292_MET_CELL  261_T_CELL  159_T_CELL  352_MET_CELL  250_T_CELL  155_T_XEN_CELL  227_T_CELL  276_T_CELL  216_T_CELL  162_T_CELL  364_MET_CELL  326_T_CELL  299_T1_CELL  190_T_CELL  152_T_CELL  330_T_CELL  108_T_XEN_CELL  116_T_XEN_CELL  327_T_CELL   G12V  G12V  G12S  G12D  G13D  Q61K  G12D  A146T  G12D  G466R  G12V  G13D   T245M, R678Q   V600E  G13D  G12S  G12V  G13D  Amp   Q61K  Amp  G466V   114_T_XEN_CELL  151_MET_CELL1  170_T2_CELL  195_T_CELL2  234_T_CELL  238_T_CELL  239_T_CELL  278_T_CELL  302_MET_CELL  315_MET_CELL  161_T_XEN_CELL  292_MET_CELL  281_T_CELL  300_T_CELL  288_MET_CELL  261_T_CELL  209_MET2_CELL  364_MET_CELL  155_T_XEN_CELL  352_MET_CELL  152_T_CELL  216_T_CELL  250_T_CELL  276_T_CELL  163_T_CELL  159_T_CELL  326_T_CELL  299_T1_CELL  227_T_CELL  330_T_CELL  190_T_CELL  162_T_CELL  116_T_XEN_CELL  327_T_CELL  108_T_XEN_CELL   G12V  Q61K  G466R  G12V  G12D  G13D  T245M, R678Q  G12D  G12S  G13D  G12D  V600E  G12V  Amp  G 12V  G12S  A146T  G13D   G13D  Amp  Q61K   114_T_XEN_CELL  151_MET_CELL1  152_T_CELL  170_T2_CELL  195_T_CELL2  216_T_CELL  238_T_CELL  239_T_CELL  278_T_CELL  292_MET_CELL  302_MET_CELL  315_MET_CELL  161_T_XEN_CELL  234_T_CELL  288_MET_CELL  261_T_CELL  159_T_CELL  300_T_CELL  163_T_CELL  352_MET_CELL  209_MET2_CELL  364_MET_CELL  155_T_XEN_CELL  116_T_XEN_CELL  330_T_CELL  227_T_CELL  190_T_CELL  162_T_CELL  281_T_CELL  108_T_XEN_CELL  299_T1_CELL  250_T_CELL  327_T_CELL  276_T_CELL  326_T_CELL   G12V  Q61K  G466R  G12V  G12D  G13D  G12D  G12S  G12D  V600E  G13D  G13D  A146T  G12S  G12V  Amp  G12V  Amp  G13D  Q61K  A864V   Q61K  G12D  G12V  Q61K  G12V  Q61H,I46F   G13D  G12D  G12V  D119E,Q22K   G12S  G13D  Fusion  G12D  A146V  G13D  G12S  G12D  G13D  G12D  G12V   R750Q   G12V   G466V G12D G12V
G12D
• • P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P S P P P P P P P P P S P P P P P P R R 150_MET1_XEN3  150_MET1_XEN2  150_MET1_XEN4  151_MET_XEN  150_MET1_XEN1  323_T_XEN  102_MET_XEN  212_T_XEN  278_T_XEN  320_T_XEN  190_T_XEN  155_T_XEN  181_T_XEN  183_T_XEN  111_T_XEN  171_MET1_XEN  209_T2_XEN  100_MET_XEN  150_MET2_XEN  161_T_XEN  261_T_XEN  150_MET1_XEN5  289_T_XEN  159_T_XEN  353_T_XEN  302_MET_XEN  184_T_XEN  280_T_XEN  352_MET_XEN  157_T_XEN  238_T_XEN  227_T_XEN  171_MET2_XEN  209_MET2_XEN  230_T_XEN  135_T_XEN  114_T_XEN  327_T_XEN  109_T_XEN  191_T_XEN  277_MET_XEN  154_MET_XEN  118_T1_XEN  139_MET_XEN  216_T_XEN  106_T_XEN  208_MET1_XEN  259_T_XEN  273_T_XEN  299_T1_XEN  208_MET2_XEN  116_T_XEN  108_T_XEN   0   25   50   75   100   125   G13D  G12V  Q61K  G12V   R750Q   G12D  G12S   T245M, R678Q   G13D  G12D  Q61K  G12S  Fusion  G12D  G12D  G12V  D119E,Q22K   G12V  G466V  G12D  Q61H,I46F   G13D  G12V  A146V  G13D  G12V  G12D  G12D   L755S • • P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P S R 150_MET1_XEN1  212_T_XEN  150_MET1_XEN2  159_T_XEN  157_T_XEN  209_T2_XEN  190_T_XEN  209_MET2_XEN  135_T_XEN  102_MET_XEN  302_MET_XEN  161_T_XEN  278_T_XEN  280_T_XEN  323_T_XEN  151_MET_XEN  261_T_XEN  352_MET_XEN  353_T_XEN  150_MET1_XEN3  181_T_XEN  238_T_XEN  150_MET1_XEN5  150_MET2_XEN  171_MET1_XEN  230_T_XEN  114_T_XEN  299_T1_XEN  100_MET_XEN  150_MET1_XEN4  320_T_XEN  327_T_XEN  171_MET2_XEN  183_T_XEN  111_T_XEN  155_T_XEN  289_T_XEN  184_T_XEN  154_MET_XEN  227_T_XEN  273_T_XEN  277_MET_XEN  216_T_XEN  108_T_XEN  191_T_XEN  208_MET1_XEN  118_T1_XEN  109_T_XEN  259_T_XEN  208_MET2_XEN  106_T_XEN  116_T_XEN E928G  V600E  V600E  V600E  V600E  V600E  V600E  V600E  V600E  V600E  V600E  V600E  V600E  V600E   0   25   50   75   100   125 Tumour Volume/Control Volume (%)   V600E  V600E  V600E  V600E  V600E  V600E  V600E  V600E  V600E  V600E  V600E  V600E   V600E   T245M, 195_T_CELL2  239_T_CELL  161_T_XEN_CELL  238_T_CELL  234_T_CELL  152_T_CELL  288_MET_CELL  315_MET_CELL  151_MET_CELL1  300_T_CELL  278_T_CELL  170_T2_CELL  162_T_CELL  261_T_CELL  163_T_CELL  209_MET2_CELL  155_T_XEN_CELL  364_MET_CELL  216_T_CELL  281_T_CELL  159_T_CELL  352_MET_CELL  330_T_CELL  292_MET_CELL  327_T_CELL  299_T1_CELL  116_T_XEN_CELL  108_T_XEN_CELL  326_T_CELL  190_T_CELL  276_T_CELL  227_T_CELL  250_T_CELL  302_MET_CELL   G12V  G12V  G13D  G12S  G12D  G12D  Q61K  G13D  G466R  V600E  A146T  G12V  G12V  Amp  G13D  G12S  Amp  Q61K  G13D 
